Your session is about to expire
← Back to Search
Other
[14C]-TNP-2092 for Healthy Subjects
Phase 1
Waitlist Available
Research Sponsored by TenNor Therapeutics Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Negative serology results for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV Ab), and human immunodeficiency virus antibody (HIV Ab)
Non-smoker (with no use of other tobacco or nicotine containing products, in any form), as documented by history (no nicotine within 6 months prior to Screening) and a negative cotinine test at Screening and Admission See Section 5.3 for details of nicotine and tobacco restrictions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights
Study Summary
This study is evaluating whether a single dose of a radioactive drug can be safely given to healthy people.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mass balance of TNP-2092 and the percentages of radiolabel recovered in urine and feces
Pharmacokinetics (PK) of TNP-2092 in plasma
Secondary outcome measures
Routes and rates of elimination of [14C] TNP 2092
Trial Design
1Treatment groups
Experimental Treatment
Group I: [14C]-TNP-2092Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[14C]-TNP-2092
2021
Completed Phase 1
~10
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
TenNor Therapeutics LimitedLead Sponsor
2 Previous Clinical Trials
133 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger